GLOBAL HEMP INDUSTRY LEADER FOLIUM BIOSCIENCES DIVERSIFIES ANIMAL HEALTH LINE AT LARGEST PET CONVENTION
Mar 19, 2019
Colorado Springs, CO, March 19 2019 – Folium Biosciences will be exhibiting at the Global Pet Expo, the pet industry’s largest annual trade show this month, presented by the American Pet Products Association (APPA) and Pet Industry Distributors Association (PIDA). The launch of specially formulated CBD-infused Bacon Dog, Salmon Cat Tinctures and Pocket Pet Pellets will be announced at the premier pet show. These brand new products were developed based on market demand to expand the already successful Animal Health line that includes Pet Tinctures, K-9 CBD-infused Beef Soft Chews and Equine Hemp Pellets. “We focus on leading the way in scientiﬁc formulation and development, to ensure we design technologically advanced phytocannabinoid-rich products that speciﬁcally serve the needs of the Animal Health space,” said CEO Kashif Shan. “This is why we brought Animal Health expert and Chief Veterinary Ofﬁcer, Dr. Robert Silver onboard 3 years ago.” Dr. Silver has over three decades of experience in the Animal Health space with a focus on phytocannabinoid-rich solutions over the last decade. He established one of the ﬁrst integrative veterinary practices in Colorado, where he pioneered herbal and dietary approaches to many of the more difﬁcult chronic conditions seen in veterinary practice. As an herbalist and integrative veterinarian in Colorado since the early 80’s, Dr. Silver was able to observe ﬁrst-hand the beneﬁts of many herbal and nutraceutical approaches to pet health including the use of cannabinoid therapeutics in pets. Dr. Silver has also provided post-graduate education to veterinarians for the past 20 years and has served on a stakeholder’s commission for the Colorado Department of Agriculture to determine the suitability of industrial hemp for animal feed in Colorado. “Animals have an endocannabinoid system much like humans and can beneﬁt from cannabinoids in the same way”, said Dr. Silver. “Our Broad Spectrum 0.0% THC oil is absolutely safe for pets as it contains no psychoactive component whatsoever.” Dr. Silver is active in the veterinary research community to help create successful animal health studies and clinical trials. He also works closely with Folium Biosciences’ VP of Product Development and Quality, M. Vanessa Fernandez, Phd, whose impressive background includes Scientiﬁc R&D and over 12 years as a cannabis ﬁeld and product development expert in Europe. “Our scientiﬁc expertise working in this space, coupled with Dr. Silver’s extensive veterinary background will serve as a foundation in building out a comprehensive product line,” commented Vanesa, who has authored numerous scientiﬁc papers in the pharmaceutical cannabinoid space. Folium Biosciences is the world’s only hemp company issued a Certiﬁcate of Free Sale and a Manufactured Food Establishment License by the Colorado Department of Public Health & Environment (CDPHE). These certiﬁcations help establish Folium Biosciences as the industry’s premier hemp company for manufacturing, processing and fulﬁlling of Folium Biosciences’ phytocannabinoid-rich CBD oil, water-soluble technologies and ﬁnished food products. No other hemp company has met the requirements needed to be licensed as a Manufactured Food Establishment and receive a Certiﬁcate of Free Sale. About Folium Biosciences Folium Biosciences is the largest vertically-integrated producer, manufacturer, and global distributor of hemp derived phytocannabinoids in North America, if not the world. It is a B2B, bulk and wholesale supplier of hemp derived CBD 0.0% THC oil, CBD water-soluble technology, CBD 0.0% THC edibles, cosmeceuticals and CBD for animal health. Folium Biosciences continues to develop rare cannabinoid extraction and product formulation and is a leader in cannabinoid technology and protocols. Folium Biosciences has over 300K square feet of manufacturing space in southern Colorado which supports processing, extraction, and puriﬁcation operations. Construction has begun on a 170K sq. ft. facility in Canada that will mirror current operations in Colorado. South American facilities are in the developing stages. Most recently, Folium Biosciences successfully acquired FeyeCon Development and Implementation, BV and FeyeCon, BV (“FeyeCon”), located in Amsterdam, B.V. FeyeCon is one of Amsterdam’s ﬁrst licensed cannabis researchers and developers and designs and fabricates custom, state-of-the-art, large scale processing equipment and supercritical CO2 extraction machinery. By manufacturing its own custom extraction, reﬁnement and post reﬁnement equipment, Folium Biosciences enjoys exclusive access to the industry’s most advanced and state-of-the-art extraction equipment. This additional level of vertical integration allows Folium Biosciences to control every phase of the production process, from seed to sale.